|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash (note 14) | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Inventories, net (Note 3) | ||||||||||||||||||||
| Related party loan (note 8) | ||||||||||||||||||||
| Prepaid expenses and other (Note 6) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net (Note 4) | ||||||||||||||||||||
| Operating lease right-of-use assets (Note 11) | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Payroll taxes payable | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities and other | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Related party loan | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Loan payable (note 12) | ||||||||||||||||||||
| Long-term debt, current portion (Note 12) | ||||||||||||||||||||
| Lease liability, current portion (Note 11) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liability, excluding current portion (Note 11) | ||||||||||||||||||||
| Long-term debt, excluding current portion (Note 12) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Series A, B and Series C preferred stock, $0.001 par value, 10,000,000 shares authorized, 100 Series A, 0 Series B, and 427,612 and 427,812 Series C issued and outstanding, respectively (Note 7) | ||||||||||||||||||||
| Common stock, $0.001 par value, 45,000,000 shares authorized, 15,282,595 and 9,814,665 shares issued and outstanding, respectively (Note 7) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Share subscriptions receivable | ||||||||||||||||||||
| Share subscriptions payable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Cumulative translation adjustment | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
